NVIV   $0.231  -35.25% Market Closed

InVivo Therapeutics Holdings Corp
Total Cash 8.58M
totalCashPerShare 2.763
EBITDA -9.80M
Total Debt 0.00
quickRatio 12.884
currentRatio 14.302
Total Revenue
debtToEquity
Revenue/Share
ROA -0.53708
ROE -0.98107004
grossProfits
freeCashflow -7.03M
operatingCashflow -10.13M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -7.59M
forwardPE
floatShares 3.10M
sharesOutstanding 3.11M
sharesShort 17.63K
sharesShortPriorMonth 357.00
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.03%
Short Ratio help_outline 0.91%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 2.872
Price To Book help_outline 0.11
earningsQuarterlyGrowth
netIncomeToCommon -9.33M
trailingEps -3.28%
forwardEps -10.80%
enterpriseToEbitda 0.77
lastDividendValue
lastDividendDate
currentQuarterEstimate 1Q 2020
institutionsCount 15
lastUpdated April 1, 2024, 12:04 p.m.